• About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • MS Symptoms
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Back on Track
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • Living well with MS
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2026
    • Participate in MS research
    • Volunteers
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • MS Symptoms
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Back on Track
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • Living well with MS
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2026
    • Participate in MS research
    • Volunteers
NEWS
RESOURCES
PODCAST
  • NEWS
  • RESOURCES
  • PODCAST
  • VIDEOS
  • CONTACT
Donate
Subscribe
Search
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • MS Symptoms
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Back on Track
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • Living well with MS
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2026
    • Participate in MS research
    • Volunteers
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • MS Symptoms
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Back on Track
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • Living well with MS
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2026
    • Participate in MS research
    • Volunteers
Ocrevus and Kesimpta & the Government’s rapid review of MS medications 22 July 2026
MS News
Ocrevus and Kesimpta & the Government’s rapid review of MS medications
Thank you! Ocrevus and Kesimpta will remain on the PBS 17 July 2026
MS News
Thank you! Ocrevus and Kesimpta will remain on the PBS
MS Australia applauds Health Minister’s announcement that Ocrevus and Kesimpta will remain on the PBS 16 July 2026
MS News
MS Australia applauds Health Minister’s announcement that Ocrevus and Kesimpta will remain on the PBS
PBS access to two vital MS treatments under threat as Government decision looms 1 July 2026
Media Release MS News
PBS access to two vital MS treatments under threat as Government decision looms
From our CEO 26 June 2026
MS News
From our CEO
Tessa Colliver 23 June 2026
LEEP MS News
Tessa Colliver
Early treatment with highly effective therapy could reduce long-term disability in children with MS 23 June 2026
MS News MS Trials
Early treatment with highly effective therapy could reduce long-term disability in children with MS
Research suggests young people with childhood-onset MS consume more ultra-processed foods 23 June 2026
MS News MS Trials
Research suggests young people with childhood-onset MS consume more ultra-processed foods
Smoking more than doubles the risk of relapse in MOGAD 23 June 2026
MS News MS Trials
Smoking more than doubles the risk of relapse in MOGAD
Incontinence and living with MS: lived experience, tips and practical strategies 16 June 2026
MS News
Incontinence and living with MS: lived experience, tips and practical strategies
Load More
MS Australia
registered charity

1300 010 158

info@msaustralia.org.au

Head Office

Suite 3.01, 18 Flour Mill Way
Summer Hill NSW 2130

Participate in MS Research

  • MS Clinical Trials
  • MS Australia Brain Bank
  • Australian MS Longitudinal Study
Facebook-f X-twitter Linkedin-in Youtube Instagram Spotify Paper-plane

Quick links

  • What is MS?
  • How is MS diagnosed?
  • COVID-19 and MS
  • Research funding opportunities
  • Research we fund
  • Media enquiries
  • Contact us
© 2026 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
© 2026 Multiple Sclerosis Australia
ABN: 51 008 515 508
Privacy Policy | Whistleblower Policy
Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Ocrevus and Kesimpta & the Government’s rapid review of MS medications